Publications by authors named "Y G M Meijer"
Clozapine is often underused due to concerns about adverse drug reactions (ADRs) but studies into their prevalences are inconclusive. We therefore comprehensively examined prevalences of clozapine-associated ADRs in individuals with schizophrenia and demographic and clinical factors associated with their occurrence. Data from a multi-center study (n = 698 participants) were collected.
View Article and Find Full Text PDFBackground: Advance Care Planning (ACP) enables patients to define and discuss their goals and preferences for future medical treatment and care. However, the structural implementation of ACP interventions remains challenging. The Multidisciplinary Timely Undertaken Advance Care Planning (MUTUAL) intervention has recently been developed which takes into account existing barriers and facilitators.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluated the effectiveness of a specific IgE test for diagnosing peanut allergies in children, aiming to reduce reliance on more invasive food challenge tests.
- It involved 150 children aged 3.5 to 18 in the Netherlands, comparing results from the IgE test with actual peanut ingestion to determine allergy status.
- The findings showed high diagnostic accuracy for the IgE test, identifying patients as peanut-tolerant or allergic, and potentially saving healthcare costs by using this method instead of national guidelines.
Background: Evidence on safety and effectiveness of omalizumab for treatment of chronic urticaria in pediatric patients is scarce and limited to case reports. In particular, drug survival of omalizumab has not yet been investigated, which is a key element in the evaluation of its clinical performance. The aim of this study was to investigate safety, effectiveness, and drug survival rates of omalizumab in a daily practice cohort of pediatric patients with chronic urticaria (CU).
View Article and Find Full Text PDFBackground: The diagnostic value of peanut components is extensively studied in children, but to a lesser extent in adults with suspected peanut allergy. The use of peanut components in daily practice may reduce the need for double-blind placebo-controlled food challenges (DBPCFCs); however, validation studies are currently lacking.
Objective: To evaluate the diagnostic value of (combined) peanut components and validate a previously found Ara h 2 cutoff level with 100% positive predictive value (PPV) in adults with suspected peanut allergy.